Cargando…
Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target
BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are rare aggressive sarcomas with poor prognosis. More than half of MPNSTs develop from benign precursor tumors associated with neurofibromatosis type 1 (NF1) which is a tumor suppressor gene disorder. Early detection of malignant transfo...
Autores principales: | Farschtschi, Said, Kluwe, Lan, Park, Su-Jin, Oh, Su-Jun, Mah, Nancy, Mautner, Victor-Felix, Kurtz, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303069/ https://www.ncbi.nlm.nih.gov/pubmed/32193699 http://dx.doi.org/10.1007/s00262-020-02548-1 |
Ejemplares similares
-
Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors
por: Park, Su-Jin, et al.
Publicado: (2013) -
Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors
por: Spyra, Melanie, et al.
Publicado: (2011) -
Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients
por: Frahm, Silke, et al.
Publicado: (2004) -
Impaired Pten Expression in Human Malignant Peripheral Nerve Sheath Tumours
por: Bradtmöller, Maren, et al.
Publicado: (2012) -
Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosis
por: Magallón-Lorenz, Miriam, et al.
Publicado: (2023)